Protamine sulfate is a basic protein derived from the sperm of salmon and certain other fish species. It is a heparin antagonist used to neutralize the anticoagulant effects of unfractionated heparin (UFH) and, to a lesser extent, low molecular weight heparins (LMWHs). It acts by forming a stable, inactive complex with heparin, thereby reversing its anticoagulant activity. It is a critical, life-saving agent used in emergency situations such as heparin overdose or to reverse heparinization after cardiopulmonary bypass surgery, vascular surgery, or dialysis. Its administration requires careful monitoring due to the risk of severe adverse effects, including hypotension, bradycardia, and anaphylaxis.
Adult: Dose is calculated based on the amount of heparin to be neutralized and the time since heparin administration. General guideline: 1 mg of protamine sulfate neutralizes approximately 100 USP units of heparin. For heparin given within 30 minutes: 1 mg/100 U heparin. For 30-60 minutes: 0.5-0.75 mg/100 U heparin. For >2 hours: 0.25-0.375 mg/100 U heparin. Maximum single dose should not exceed 50 mg. Administer by slow IV injection over 10 minutes.
Note: For IV use only. MUST be administered as a slow intravenous injection over at least 10 minutes. Rapid injection can cause severe hypotension, bradycardia, and anaphylactoid reactions. Should be administered in a setting with resuscitation equipment and drugs (epinephrine, corticosteroids, antihistamines) readily available. Do not mix with other drugs or infusions.
Protamine sulfate is a strongly basic (cationic) protein that binds ionically to the strongly acidic (anionic) heparin molecule. This electrostatic interaction forms a stable, biologically inactive salt complex (1:1 weight ratio for UFH). This binding neutralizes the anticoagulant effect of heparin by displacing antithrombin III from the heparin-ATIII complex, thereby inhibiting the acceleration of antithrombin-mediated inactivation of coagulation factors (primarily thrombin and factor Xa).
Pregnancy: US FDA Category C. Animal reproduction studies not conducted. Should be used only if clearly needed, as heparin reversal may be critical for maternal health. Benefits generally outweigh risks in emergency situations.
Driving: Not relevant. Administered in a controlled clinical setting.
| Insulin (particularly NPH insulin) | Patients on NPH insulin may be sensitized to protamine, increasing risk of hypersensitivity reactions. | Moderate |
| Antihypertensive drugs, Vasodilators | Additive hypotensive effect. Risk of severe hypotension. | Major |
| Heparin | Therapeutic interaction: Forms inactive complex. Excess protamine itself has anticoagulant effect. | Major |
| Cephalosporins, Penicillins | Theoretical increased risk of hypersensitivity reactions. | Minor |
Same composition (Protamine sulfate (NA)), different brands: